Cataract Surgery

33-48 of 948

• 

  RestartResume

  Cataract Surgery After a Phakic IOL

  RestartResume

  Cataract Surgery After a Phakic IOL

  Cataract Surgery

  Cataract Surgery After a Phakic IOL

  Audrey R. Talley Rostov, MD; Rupert Menapace, MD, FEBO

  Audrey R. Talley Rostov, MD; Rupert Menapace, MD, FEBO

• 

  RestartResume

  Small–Aperture Technology for Presbyopia

  RestartResume

  Small–Aperture Technology for Presbyopia

  Cataract Surgery

  Small–Aperture Technology for Presbyopia

  Bernardo De Padua Soares Bezerra, MD

  Bernardo De Padua Soares Bezerra, MD

• 

  RestartResume

  Using Basic Diagnostic Principles to Guide Treatment Decisions

  RestartResume

  Using Basic Diagnostic Principles to Guide Treatment Decisions

  Cataract Surgery

  Using Basic Diagnostic Principles to Guide Treatment Decisions

  Stefano Barabino, MD, PhD

  Stefano Barabino, MD, PhD

• 

  RestartResume

  IOL Selection in Patients With DED

  RestartResume

  IOL Selection in Patients With DED

  Cataract Surgery

  IOL Selection in Patients With DED

  Federico Solignani, MD

  Federico Solignani, MD

• 

  RestartResume

  Starting a Dry Eye Clinic

  RestartResume

  Starting a Dry Eye Clinic

  Cataract Surgery

  Starting a Dry Eye Clinic

  Detlef Holland, MD

  Detlef Holland, MD

• 

  RestartResume

  Retained Nuclear Chips

  RestartResume

  Retained Nuclear Chips

  Cataract Surgery

  Retained Nuclear Chips

  Lisa Brothers Arbisser, MD; Rebekah Allen, MD, MS

  Lisa Brothers Arbisser, MD; Rebekah Allen, MD, MS

• 

  RestartResume

  Hair-Raising Issues in Eye Cosmetics

  RestartResume

  Hair-Raising Issues in Eye Cosmetics

  Cataract Surgery

  Hair-Raising Issues in Eye Cosmetics

  Laura M. Periman, MD

  Laura M. Periman, MD

• 

  RestartResume

  The Role of Growth Factor in DED

  RestartResume

  The Role of Growth Factor in DED

  Cataract Surgery

  The Role of Growth Factor in DED

  Mary Davidian, MD

  Mary Davidian, MD

• 

  RestartResume

  Hormone Therapy for DED

  RestartResume

  Hormone Therapy for DED

  Cataract Surgery

  Hormone Therapy for DED

  Mark S. Milner, MD

  Mark S. Milner, MD

• 

  RestartResume

  Successful Implementation of IPL Therapy

  RestartResume

  Successful Implementation of IPL Therapy

  Cataract Surgery

  Successful Implementation of IPL Therapy

  Richard A. Adler, MD

  Richard A. Adler, MD

• 

  RestartResume

  Identifying and Managing Neuropathic Pain in Dry Eye

  RestartResume

  Identifying and Managing Neuropathic Pain in Dry Eye

  Cataract Surgery

  Identifying and Managing Neuropathic Pain in Dry Eye

  Divy Mehra, BS; Anat Galor, MD, MSPH

  Divy Mehra, BS; Anat Galor, MD, MSPH

• 

  RestartResume

  Allergy and DED

  RestartResume

  Allergy and DED

  Cataract Surgery

  Allergy and DED

  Alice T. Epitropoulos, MD

  Alice T. Epitropoulos, MD

• 

  RestartResume

  Presurgical Management of DED

  RestartResume

  Presurgical Management of DED

  Cataract Surgery

  Presurgical Management of DED

  Marjan Farid, MD

  Marjan Farid, MD

• 

  RestartResume

  Case Studies in Pupil Dilation

  RestartResume

  Case Studies in Pupil Dilation

  Cataract Surgery

  Case Studies in Pupil Dilation

  Eric Donnenfeld, MD; Cristos Ifantides, MD, MBA

  Eric Donnenfeld, MD; Cristos Ifantides, MD, MBA

• 

  RestartResume

  Wound Gape Transposition Procedure

  RestartResume

  Wound Gape Transposition Procedure

  Cataract Surgery

  Wound Gape Transposition Procedure

  Edward Yavitz, MD

  Edward Yavitz, MD

• 

  RestartResume

  IOLs in the Pipeline

  RestartResume

  IOLs in the Pipeline

  Cataract Surgery

  IOLs in the Pipeline

  Kerry Assil, MD; Uday Devgan, MD, FACS, FRCS

  Kerry Assil, MD; Uday Devgan, MD, FACS, FRCS